These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9284083)

  • 41. Urinary excretion of zinc, copper and iron in the streptozotocin-diabetic rat.
    Lau AL; Failla ML
    J Nutr; 1984 Jan; 114(1):224-33. PubMed ID: 6363637
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regeneration of the heart in diabetes by selective copper chelation.
    Cooper GJ; Phillips AR; Choong SY; Leonard BL; Crossman DJ; Brunton DH; Saafi 'L; Dissanayake AM; Cowan BR; Young AA; Occleshaw CJ; Chan YK; Leahy FE; Keogh GF; Gamble GD; Allen GR; Pope AJ; Boyd PD; Poppitt SD; Borg TK; Doughty RN; Baker JR
    Diabetes; 2004 Sep; 53(9):2501-8. PubMed ID: 15331567
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Copper, zinc, and selenium in human blood and urine after injection of sodium 2,3-dimercaptopropane-1-sulfonate: a study on subjects with dental amalgam.
    Høl PJ; Vamnes JS; Gjerdet NR; Eide R; Isrenn R
    Biol Trace Elem Res; 2003 Jan; 91(1):19-31. PubMed ID: 12713026
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determination and metabolism of dithiol chelating agents. III. Formation of oxidized metabolites of 2,3-dimercaptopropane-1-sulfonic acid in rabbit.
    Maiorino RM; Weber GL; Aposhian HV
    Drug Metab Dispos; 1988; 16(3):455-63. PubMed ID: 2900740
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice.
    Hoogenraad TU
    Brain Dev; 2006 Apr; 28(3):141-6. PubMed ID: 16466879
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Wilson's disease: current status.
    Yarze JC; Martin P; Muñoz SJ; Friedman LS
    Am J Med; 1992 Jun; 92(6):643-54. PubMed ID: 1605146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pregnancy in a patient with Wilson's disease treated with D-penicillamine and zinc sulfate. A case report and review of the literature.
    Hartard C; Kunze K
    Eur Neurol; 1994; 34(6):337-40. PubMed ID: 7851456
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
    Walshe JM
    QJM; 2011 Sep; 104(9):775-8. PubMed ID: 21622540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Penicillamine and the SLE syndrome.
    Walshe JM
    J Rheumatol Suppl; 1981; 7():155-60. PubMed ID: 6939878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Concentration of Zinc, Copper, Iron, Calcium, and Magnesium in the Serum, Tissues, and Urine of Streptozotocin-Induced Mild Diabetic Rat Model.
    Gómez T; Bequer L; Mollineda A; Molina JL; Álvarez A; Lavastida M; Clapés S
    Biol Trace Elem Res; 2017 Oct; 179(2):237-246. PubMed ID: 28258359
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
    Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
    Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Copper(I)-binding properties of de-coppering drugs for the treatment of Wilson disease. α-Lipoic acid as a potential anti-copper agent.
    Smirnova J; Kabin E; Järving I; Bragina O; Tõugu V; Plitz T; Palumaa P
    Sci Rep; 2018 Jan; 8(1):1463. PubMed ID: 29362485
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral zinc therapy for Wilson's disease.
    Brewer GJ; Hill GM; Prasad AS; Cossack ZT; Rabbani P
    Ann Intern Med; 1983 Sep; 99(3):314-9. PubMed ID: 6614680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Wilson's disease in one identical twin and treatment by triethylene tetramine 2HCl in another case.
    Watson RG
    Ulster Med J; 1983; 52(1):48-53. PubMed ID: 6687321
    [No Abstract]   [Full Text] [Related]  

  • 55. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
    J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distribution of copper, iron, and zinc in biological samples (scalp hair, serum, blood, and urine) of Pakistani viral hepatitis (A-E) patients and controls.
    Kolachi NF; Kazi TG; Afridi HI; Kazi N; Kandhro GA; Shah AQ; Baig JA; Wadhwa SK; Khan S; Shah F; Jamali MK; Arain MB
    Biol Trace Elem Res; 2011 Oct; 143(1):116-30. PubMed ID: 20872092
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Haemolytic activity of copper as influenced by chelating agents, albumine and chromium.
    Aaseth J; Skaug V; Alexander J
    Acta Pharmacol Toxicol (Copenh); 1984 Apr; 54(4):304-10. PubMed ID: 6730985
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The urinary excretion of radiocopper in presymptomatic and symptomatic Wilson's disease, heterozygotes and controls: its significance in diagnosis and management.
    Gibbs K; Hanka R; Walshe JM
    Q J Med; 1978 Jul; 47(187):349-64. PubMed ID: 715173
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chelating polymeric beads as potential therapeutics for Wilson's disease.
    Mattová J; Poučková P; Kučka J; Skodová M; Vetrík M; Stěpánek P; Urbánek P; Petřík M; Nový Z; Hrubý M
    Eur J Pharm Sci; 2014 Oct; 62():1-7. PubMed ID: 24815561
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Zinc, copper, and iron balance in elderly men.
    Turnlund J; Costa F; Margen S
    Am J Clin Nutr; 1981 Dec; 34(12):2641-7. PubMed ID: 7315765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.